Parkinson Disease Treatment in Hospitals and Nursing Facilities: Avoiding Pitfalls

被引：19
作者：
Ahlskog, J. Eric [1 ]
机构：
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
来源：
MAYO CLINIC PROCEEDINGS | 2014年 / 89卷 / 07期
关键词：
PAIN THRESHOLD; LEVODOPA; ROPINIROLE; INHIBITORS;
D O I：
10.1016/j.mayocp.2014.02.018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The unique needs of patients with Parkinson disease challenge staff when such patients are admitted to hospitals or nursing facilities. Prolongation of the hospital stay, falls with injuries, fainting, or declining motor function may result from therapeutic misadventures or failure to anticipate common problems. Staff familiarity with Parkinson disease, and especially carbidopa-levodopa dosing and dynamics, may prevent such problems and streamline hospital and nursing home care. (C) 2014 Mayo Foundation for Medical Education and Research
引用
收藏
页码：997 / 1003
页数：7
相关论文
共 14 条
  • [1] Rasagiline, Parkinson neuroprotection, and delayed-start trials Still no satisfaction?
    Ahlskog, J. Eric
    Uitti, Ryan J.
    [J]. NEUROLOGY, 2010, 74 (14) : 1143 - 1148
  • [2] CONTROLLED-RELEASE SINEMET (CR-4) - A DOUBLE-BLIND CROSSOVER STUDY IN PATIENTS WITH FLUCTUATING PARKINSONS-DISEASE
    AHLSKOG, JE
    MUENTER, MD
    MCMANIS, PG
    BELL, GN
    BAILEY, PA
    [J]. MAYO CLINIC PROCEEDINGS, 1988, 63 (09) : 876 - 886
  • [3] Ahlskog JE, 2005, PARKINSONS DIS TREAT, P532
  • [4] Ahlskog JE, 2009, PARKINSONS DIS TREAT, P382
  • [5] Ahlskog JE, 2013, DEMENTIA LEWY BODIES, P244
  • [6] New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease
    Bonifati, V
    Meco, G
    [J]. PHARMACOLOGY & THERAPEUTICS, 1999, 81 (01) : 1 - 36
  • [7] Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
    Brefel-Courbon, C
    Payoux, P
    Thalamas, C
    Ory, F
    Quelven, I
    Chollet, F
    Montastruc, JL
    Rascol, O
    [J]. MOVEMENT DISORDERS, 2005, 20 (12) : 1557 - 1563
  • [8] SLOW RECOVERY OF HUMAN BRAIN MAO-B AFTER L-DEPRENYL (SELEGELINE) WITHDRAWAL
    FOWLER, JS
    VOLKOW, ND
    LOGAN, J
    WANG, GJ
    MACGREGOR, RR
    SCHLYER, D
    WOLF, AP
    PAPPAS, N
    ALEXOFF, D
    SHEA, C
    DORFLINGER, E
    KRUCHOWY, L
    YOO, K
    FAZZINI, E
    PATLAK, C
    [J]. SYNAPSE, 1994, 18 (02) : 86 - 93
  • [9] Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study
    Gerdelat-Mas, A.
    Simonetta-Moreau, M.
    Thalamas, C.
    Ory-Magne, F.
    Slaoui, T.
    Rascol, O.
    Brefel-Courbon, C.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (10) : 1140 - 1142
  • [10] Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum
    Gerlach, M
    Double, K
    Arzberger, T
    Leblhuber, F
    Tatschner, T
    Riederer, P
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (10) : 1119 - 1127
12